Скачать с ютуб The Latest in Early Detection for Pancreatic Cancer в хорошем качестве

The Latest in Early Detection for Pancreatic Cancer

PanCAN President and CEO Julie Fleshman, JD, MBA, welcomes a panel of pancreatic cancer experts for question-and-answer session discussing the latest efforts to detect pancreatic cancer, including: pancreatic cancer risk factors, novel blood tests and PanCAN’s investment in early detection and the launch of the Early Detection Initiative. The panel includes Lynn Matrisian, PhD, MBA – PanCAN, Rosalie Sears, PhD – Oregon Health & Science University, and Brian M. Wolpin, MD, MPH – Dana-Farber Cancer Institute. ################ Do you know someone diagnosed with pancreatic cancer? The expert Patient Services case managers at PanCAN partner with patients and families at every step, offering free, personalized information and resources. Call 877-2-PANCAN, email [email protected] or visit http://pcan.at/pty. Associates are available Monday – Friday, 7 a.m. – 5 p.m. PT. ################ CONNECT WITH US WEBSITE: http://pcan.at/PC FACEBOOK:   / pancan   TWITTER:   / pancan   INSTAGRAM:   / pancan   YOUTUBE:    / stoppancreaticcancer​   ################ ABOUT PANCREATIC CANCER ACTION NETWORK The Pancreatic Cancer Action Network’s (PanCAN) vision is to create a world in which all patients with pancreatic cancer will thrive. Our mission is to take bold action to improve the lives of everyone impacted by pancreatic cancer by advancing scientific research, building community, sharing knowledge, and advocating for patients. Thank you to our webinar sponsors Ipsen and Sylvester Comprehensive Cancer Center and to our Scientific & Medical Affairs Industry Members AbbVie, AstraZeneca, FibroGen, Ipsen, Pfizer, Rafael Pharmaceuticals, Tempus and TYME.